NewsDaVita Responds to Trial Results of Novo Nordisk's Ozempic Treatment By InvestLuck October 12, 2023 1 Mins read Dialysis company DaVita Inc. has issued a statement in response to the recent news from Novo Nordisk regarding its Ozempic treatment for… Read more
